A detailed history of Kera Capital Partners, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 4,116 shares of JNJ stock, worth $688,442. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,116
Previous 3,077 33.77%
Holding current value
$688,442
Previous $510 Million 99.88%
% of portfolio
0.13%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 01, 2025

BUY
$146.36 - $159.82 $152,068 - $166,052
1,039 Added 33.77%
4,116 $628,000
Q1 2025

Apr 02, 2025

BUY
$142.06 - $167.7 $91,912 - $108,501
647 Added 26.63%
3,077 $510 Million
Q4 2024

Jan 15, 2025

BUY
$143.34 - $165.86 $348,316 - $403,039
2,430 New
2,430 $351 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $437B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kera Capital Partners, Inc. Portfolio

Follow Kera Capital Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kera Capital Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kera Capital Partners, Inc. with notifications on news.